HIA
GNOM icon

Harbor Investment Advisory’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Harbor Investment Advisory’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9
Closed -$1K – 1276
2021
Q1 		$1K Buy
+9
New +$888 ﹤0.01% 1215

Other funds holding GNOM

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Harbor Investment Advisory's GNOM Position: Q2 2021 in Review

Harbor Investment Advisory sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2021, closing a stake of 9 shares — an estimated $1K sold.

Harbor Investment Advisory first reported a position in GNOM in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 45 funds tracked by Wall St. Rank hold GNOM as of Q2 2021.

  • Harbor Investment Advisory reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
  • Harbor Investment Advisory sold 9 Global X Genomics & Biotechnology ETF shares in Q2 2021, an estimated $1K.
  • Harbor Investment Advisory first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 1 quarter.
  • Harbor Investment Advisory's Global X Genomics & Biotechnology ETF position peaked at $1K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2021.

Based on Harbor Investment Advisory's 13F filing for Q2 2021, filed 27 Jul 2021.